Global Non-Invasive Cancer Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • ID:PD038237
  • April 2021
  • GIR (Global Info Research)
                          

The Global Non-Invasive Cancer Diagnostics Market Report is equipped with market data from 2016 to 2026. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2021 to 2026. The detailed sales channel is also covered in the study.

The Non-Invasive Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Non-Invasive Cancer Diagnostics size is estimated to be USD 129290 million in 2026 from USD 111670 million in 2020, with a change XX% between 2020 and 2021. The global Non-Invasive Cancer Diagnostics market size is expected to grow at a CAGR of 3.7% for the next five years.

Market segmentation
Non-Invasive Cancer Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

  •     CTCs
  •     CTNAS
  •     Exosomes

Market segment by Application, can be divided into
  •     Blood
  •     Urine
  •     Saliva

Market segment by players, this report covers
  •     Gen-Probe Inc
  •     Digene Corporation
  •     Quest Diagnostics Inc
  •     Cancer, Genetics Inc
  •     BIOVIEW Inc
  •     AVIVA Biosciences Corporation
  •     Laboratory Corporation of America Holdings (LabCorp)
  •     A&G Pharmaceutical
  •     Affymetrix Inc
  •     Precision Therapeutics

Market segment by regions, regional analysis covers
  •     North America (United States, Canada, and Mexico)
  •     Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  •     Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
  •     South America (Brazil, Argentina, Rest of South America)
  •     Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Non-Invasive Cancer Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Non-Invasive Cancer Diagnostics, with revenue, gross margin and global market share of Non-Invasive Cancer Diagnostics from 2019 to 2021.
Chapter 3, the Non-Invasive Cancer Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Non-Invasive Cancer Diagnostics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Non-Invasive Cancer Diagnostics research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Non-Invasive Cancer Diagnostics
    1.2 Classification of Non-Invasive Cancer Diagnostics by Type
        1.2.1 Overview: Global Non-Invasive Cancer Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type in 2020
        1.2.3 CTCs
        1.2.4 CTNAS
        1.2.5 Exosomes
    1.3 Global Non-Invasive Cancer Diagnostics Market by Application
        1.3.1 Overview: Global Non-Invasive Cancer Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Blood
        1.3.3 Urine
        1.3.4 Saliva
    1.4 Global Non-Invasive Cancer Diagnostics Market Size & Forecast
    1.5 Global Non-Invasive Cancer Diagnostics Market Size and Forecast by Region
        1.5.1 Global Non-Invasive Cancer Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Non-Invasive Cancer Diagnostics Market Size by Region, (2016-2021)
        1.5.3 North America Non-Invasive Cancer Diagnostics Market Size and Prospect (2016-2026)
        1.5.4 Europe Non-Invasive Cancer Diagnostics Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size and Prospect (2016-2026)
        1.5.6 South America Non-Invasive Cancer Diagnostics Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Non-Invasive Cancer Diagnostics Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Non-Invasive Cancer Diagnostics Market Drivers
        1.6.2 Non-Invasive Cancer Diagnostics Market Restraints
        1.6.3 Non-Invasive Cancer Diagnostics Trends Analysis
2 Company Profiles
    2.1 Gen-Probe Inc
        2.1.1 Gen-Probe Inc Details
        2.1.2 Gen-Probe Inc Major Business
        2.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Product and Solutions
        2.1.4 Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Gen-Probe Inc Recent Developments and Future Plans
    2.2 Digene Corporation
        2.2.1 Digene Corporation Details
        2.2.2 Digene Corporation Major Business
        2.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Product and Solutions
        2.2.4 Digene Corporation Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Digene Corporation Recent Developments and Future Plans
    2.3 Quest Diagnostics Inc
        2.3.1 Quest Diagnostics Inc Details
        2.3.2 Quest Diagnostics Inc Major Business
        2.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product and Solutions
        2.3.4 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Quest Diagnostics Inc Recent Developments and Future Plans
    2.4 Cancer, Genetics Inc
        2.4.1 Cancer, Genetics Inc Details
        2.4.2 Cancer, Genetics Inc Major Business
        2.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product and Solutions
        2.4.4 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Cancer, Genetics Inc Recent Developments and Future Plans
    2.5 BIOVIEW Inc
        2.5.1 BIOVIEW Inc Details
        2.5.2 BIOVIEW Inc Major Business
        2.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Product and Solutions
        2.5.4 BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 BIOVIEW Inc Recent Developments and Future Plans
    2.6 AVIVA Biosciences Corporation
        2.6.1 AVIVA Biosciences Corporation Details
        2.6.2 AVIVA Biosciences Corporation Major Business
        2.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product and Solutions
        2.6.4 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 AVIVA Biosciences Corporation Recent Developments and Future Plans
    2.7 Laboratory Corporation of America Holdings (LabCorp)
        2.7.1 Laboratory Corporation of America Holdings (LabCorp) Details
        2.7.2 Laboratory Corporation of America Holdings (LabCorp) Major Business
        2.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product and Solutions
        2.7.4 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Developments and Future Plans
    2.8 A&G Pharmaceutical
        2.8.1 A&G Pharmaceutical Details
        2.8.2 A&G Pharmaceutical Major Business
        2.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product and Solutions
        2.8.4 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 A&G Pharmaceutical Recent Developments and Future Plans
    2.9 Affymetrix Inc
        2.9.1 Affymetrix Inc Details
        2.9.2 Affymetrix Inc Major Business
        2.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Product and Solutions
        2.9.4 Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Affymetrix Inc Recent Developments and Future Plans
    2.10 Precision Therapeutics 
        2.10.1 Precision Therapeutics Details
        2.10.2 Precision Therapeutics Major Business
        2.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Product and Solutions
        2.10.4 Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Precision Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Non-Invasive Cancer Diagnostics Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Non-Invasive Cancer Diagnostics Players Market Share
        3.2.2 Top 10 Non-Invasive Cancer Diagnostics Players Market Share
        3.2.3 Market Competition Trend
    3.3 Non-Invasive Cancer Diagnostics Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Non-Invasive Cancer Diagnostics Revenue and Market Share by Type (2016-2021)
    4.2 Global Non-Invasive Cancer Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Application (2016-2021)
    5.2 Non-Invasive Cancer Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Non-Invasive Cancer Diagnostics Revenue by Type (2016-2026)
    6.2 North America Non-Invasive Cancer Diagnostics Revenue by Application (2016-2026)
    6.3 North America Non-Invasive Cancer Diagnostics Market Size by Country
        6.3.1 North America Non-Invasive Cancer Diagnostics Revenue by Country (2016-2026)
        6.3.2 United States Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        6.3.3 Canada Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        6.3.4 Mexico Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Non-Invasive Cancer Diagnostics Revenue by Type (2016-2026)
    7.2 Europe Non-Invasive Cancer Diagnostics Revenue by Application (2016-2026)
    7.3 Europe Non-Invasive Cancer Diagnostics Market Size by Country
        7.3.1 Europe Non-Invasive Cancer Diagnostics Revenue by Country (2016-2026)
        7.3.2 Germany Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        7.3.3 France Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        7.3.5 Russia Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        7.3.6 Italy Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Non-Invasive Cancer Diagnostics Revenue by Type (2016-2026)
    8.2 Asia-Pacific Non-Invasive Cancer Diagnostics Revenue by Application (2016-2026)
    8.3 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size by Region
        8.3.1 Asia-Pacific Non-Invasive Cancer Diagnostics Revenue by Region (2016-2026)
        8.3.2 China Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        8.3.3 Japan Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        8.3.4 South Korea Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        8.3.5 India Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        8.3.7 Australia Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Non-Invasive Cancer Diagnostics Revenue by Type (2016-2026)
    9.2 South America Non-Invasive Cancer Diagnostics Revenue by Application (2016-2026)
    9.3 South America Non-Invasive Cancer Diagnostics Market Size by Country
        9.3.1 South America Non-Invasive Cancer Diagnostics Revenue by Country (2016-2026)
        9.3.2 Brazil Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        9.3.3 Argentina Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Non-Invasive Cancer Diagnostics Revenue by Type (2016-2026)
    10.2 Middle East & Africa Non-Invasive Cancer Diagnostics Revenue by Application (2016-2026)
    10.3 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Country
        10.3.1 Middle East & Africa Non-Invasive Cancer Diagnostics Revenue by Country (2016-2026)
        10.3.2 Turkey Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
        10.3.4 UAE Non-Invasive Cancer Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..